Results 161 to 170 of about 41,565 (267)

Impaired cerebrovascular reactivity is associated with disability and cognitive performance in relapsing-remitting multiple sclerosis. [PDF]

Neurol Sci
Ntais E, Kostadima V, Haski A, Tsamis K, Giannopoulos S, Konitsiotis S.   +5 more
europepmc   +1 more source

Brain atrophy rates vary with age in relapsing-remitting multiple sclerosis. [PDF]

J Neurol Neurosurg Psychiatry
Kaçar S, van Nederpelt DR, Jelgerhuis JR, Coerver EME, Killestein J, Sormani MP, Ciccarelli O, Arnold DL, van Kempen ZLE, Uitdehaag BMJ, Barkhof F, Koch MW, Schoonheim MM, Eshaghi A, Strijbis EMM.   +14 more
europepmc   +1 more source

Digital monitoring of disease activity in relapsing-remitting multiple sclerosis. [PDF]

J Neurol
Molenaar PCG, de Jong DJ, Hof SN, van Oirschot P, Bucur IG, Lam KH, Moraal B, Heskes TM, de Groot V, Uitdehaag BMJ, de Jong BA, Twisk JWR, Strijbis EMM, Killestein J.   +13 more
europepmc   +1 more source

Identification of diagnostic biomarkers for relapsing-remitting multiple sclerosis in plasma by mass spectrometry-based proteomics. [PDF]

J Neuropathol Exp Neurol
García-Silva VM, Chicano-Galvez E, García-Sánchez MI, Peralbo-Molina Á, Hernández-Valladares M.   +4 more
europepmc   +1 more source

Ocrelizumab in early relapsing-remitting multiple sclerosis: first interim analysis of the MUSPO Italian prospective cohort. [PDF]

J Neurol
Filippi M, D'Amico E, Brescia Morra V, Zanetta C, Zanghì A, Di Filippo PS, Longobardi E, Colombo E, Mirabella M, Conte A, Tomassini V, Masini C, Perosino V, Tortorella P, Rocca MA, MUPSO Study Group.   +15 more
europepmc   +1 more source

Investigating Depression and MRI Associations in Middle Eastern Relapsing-Remitting Multiple Sclerosis. [PDF]

J Biomed Phys Eng
Pishdad P, Zeinali-Rafsanjani B, Poursadeghfard M, Kalaee M, Ostovarfar J, Salehi A.   +5 more
europepmc   +1 more source

Cross-sectional brain volumetric measures and disability outcomes in relapsing-remitting multiple sclerosis. [PDF]

J Neurol
Hayes MTG, Beadnall HN, Merlo D, Monif M, Zhu C, Barnett M, Buzzard K, Horakova D, Kalincik T, Laureys G, Lui E, Lechner-Scott J, Nguyen AL, Patti F, Sima DM, Smeets D, Vaneckova M, Van Hecke W, Van Pesch V, van der Walt A, Butzkueven H.   +20 more
europepmc   +1 more source

Cost-Effectiveness of Dimethyl Fumarate Versus Teriflunomide in Patients With Relapsing-Remitting Multiple Sclerosis (RRMS) in Iran. [PDF]

Health Sci Rep
Poursadeghfard M, Farjah Y, Rezaee M, Momtahan N, Morowvat MH, Gholami A, Keshavarz K.   +6 more
europepmc   +1 more source

Preliminary Psychometric Evaluation of the Romanian Version of the Hospital Anxiety and Depression Scale in Relapsing-Remitting Multiple Sclerosis. [PDF]

J Clin Med
Böckels L, Lisnic V, Alexa D, Belenciuc A, Crețu RA, Ropot D, Bîlcu RV, Cuciureanu DI.   +7 more
europepmc   +1 more source

Central Vein Sign and Paramagnetic Rim Lesions in Patients with Relapsing-Remitting Multiple Sclerosis: An Assessment of Prevalence and Anatomical Location. [PDF]

Neurol Int
Jansone MN, Zdanovskis N, Polunosika E, Pastare D, Karelis G.   +4 more
europepmc   +1 more source